Aphria Inc (TSE:APH) – Equities research analysts at Clarus Securities reduced their FY2019 EPS estimates for Aphria in a research note issued to investors on Thursday. Clarus Securities analyst N. Atkinson now anticipates that the company will post earnings per share of $0.38 for the year, down from their previous estimate of $0.39.
Separately, Canaccord Genuity lifted their price target on shares of Aphria from C$8.25 to C$14.00 in a research note on Tuesday, December 5th.
TRADEMARK VIOLATION WARNING: This news story was first posted by American Banking News and is the property of of American Banking News. If you are viewing this news story on another site, it was copied illegally and reposted in violation of international copyright & trademark law. The correct version of this news story can be read at https://www.americanbankingnews.com/2018/01/05/fy2019-eps-estimates-for-aphria-inc-aph-lowered-by-analyst.html.
Aphria Inc produces, supplies, and sells medical cannabis in Canada. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It also provides support services in the form of medical consultations, group therapies, and rehabilitation to veteran and first responders.
Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.